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Abstract
Viruses diversify over time within hosts, often undercutting the effectiveness of host defenses and therapeutic interventions.
To design successful vaccines and therapeutics, it is critical to better understand viral diversification, including
comprehensively characterizing the genetic variants in viral intra-host populations and modeling changes from
transmission through the course of infection. Massively parallel sequencing technologies can overcome the cost constraints
of older sequencing methods and obtain the high sequence coverage needed to detect rare genetic variants (,1%) within
an infected host, and to assay variants without prior knowledge. Critical to interpreting deep sequence data sets is the
ability to distinguish biological variants from process errors with high sensitivity and specificity. To address this challenge,
we describe V-Phaser, an algorithm able to recognize rare biological variants in mixed populations. V-Phaser uses covariation
(i.e. phasing) between observed variants to increase sensitivity and an expectation maximization algorithm that iteratively
recalibrates base quality scores to increase specificity. Overall, V-Phaser achieved .97% sensitivity and .97% specificity on
control read sets. On data derived from a patient after four years of HIV-1 infection, V-Phaser detected 2,015 variants across
the ,10 kb genome, including 603 rare variants (,1% frequency) detected only using phase information. V-Phaser
identified variants at frequencies down to 0.2%, comparable to the detection threshold of allele-specific PCR, a method that
requires prior knowledge of the variants. The high sensitivity and specificity of V-Phaser enables identifying and tracking
changes in low frequency variants in mixed populations such as RNA viruses.
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Introduction
Genetic differences can arise among individual viral particles
within an infected host, and detecting these viral genetic variants
can reveal how viruses adapt to challenges such as host immune
responses, antiviral medications, and transmission bottlenecks.
However, detecting rare variants is difficult with existing
sequencing technologies due to low sensitivity, high error rates,
and/or poor scalability. For example, bulk-sequencing approaches
generate a consensus assembly, but they have limited sensitivity to
detect intra-host variation [1]. One approach to increase
sensitivity is to amplify and clone selected fragments of viral
nucleic acids into proliferating targets that are subsequently
isolated and sequenced [2], but this method has a higher false
positive rate and poor scalability. To reduce errors, the single
genome amplification (SGA) method isolates individual viral
genomes through dilution, and then amplifies and sequences each
genome individually to minimize introduced errors [3–5],
although scalability remains an issue. Rare variant detection
requires deep coverage that is not cost-effective with current
methods of cloning or SGA. To address scalability, massively
parallel sequencing technologies can isolate and sequence
individual DNA or cDNA molecules en masse from the population
of viral genomes and generate millions of short read sequences that
can increase the sensitivity and decrease the cost to detect variants
[6,7]. Still, increased error rates can somewhat impact potential
gains in sensitivity. Here, we report on a novel method to detect
rare variants that increases sensitivity even in the presence of
process errors.
Detecting biological variants involves not only finding them,
which deep sequencing technologies can do with high sensitivity,
but also differentiating them from process (i.e. amplification or
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distribution of errors. For example, several authors have reported
using a Poisson or binomial probability model to define the error
distribution, and they can call candidates that fall outside the
distribution variants [8–13]. These models, however, assume that
all bases have equal quality scores, where the base quality score is a
measure of how accurate the base call is. This assumption is
invalid for bases measured by massively parallel sequencing
technologies, as Brockman et al. [14] have shown, since base
quality can vary by several criteria; in fact, sequencing
technologies take criteria such as these into account when
assigning base quality scores. To avoid this assumption, probability
models can incorporate base quality scores. Such probability
models exist in tools that call single nucleotide polymorphisms
(SNPs) in human and other diploid genomes, including MAQ
[15], SoapSNP [16], Unified Genotyper [17], SNVMix [18], or
Slider [19]. In contrast, instead of an explicit error probability
model, Hoffman et al. [20] compare variants to an empirical
control data set. Archer et al. [21] and Rozera et al. [22] report
methods that correct read sequences for suspected process errors
prior to calculating variant frequencies. Archer et al. [21] use a k-
mer mapping approach to position reads on a consensus template
and refine alignments locally, and Rozera et al. [22] turn to
heuristic rules to filter out errors based on cutoffs for base quality
scores and other criteria. Both strategies avoid using an explicit
probability model of error and hence assume that all process errors
take a specific form, and that no biological variants take the same
form as the process errors.
The above models separate variants from error using specific
forms or heuristics or a probabilistic distribution. An alternative
approach is to consider patterns of candidate variants. For
example, Eriksson et al. [9] use Fisher’s exact test to find patterns
that occur more frequently than expected by chance to call
variants. Refining this approach further, several authors probabi-
listically cluster patterns to infer variant haplotypes [9,11,12,23];
the cluster centers are haplotypes, and process errors can be
removed by collapsing variation within the cluster. Since patterns
of variants are essentially groups of variants that occur at the same
loci on multiple reads, i.e. in phase, we can analyze them together
as a group of phased variants, and we can compare them to
phased errors in the same pattern. Phased errors presumably occur
much less frequently than errors in general, making it easier to
recognize phased variants.
To address the challenge of calling rare genetic variants in
diverse populations in the presence of error, we introduce V-Phaser,
a single nucleotide variant calling tool that uses phase and quality
filtering with a probability model that incorporates and recali-
brates individual base quality scores. To increase sensitivity, V-
Phaser looks not only for variants that fall outside the distribution of
errors but also for patterns of variants in phase. To increase
specificity, it incorporates individual base quality scores into a
composite Bernoulli model that allows error rates to vary from
base to base. It also uses a pre-processing filter to screen out low
quality bases and improve the fit of the model. We calculate the
theoretical gain in sensitivity of detecting variants using phase to
increase specificity. We then validate V-Phaser on read sets with
known variation generated by the 454 sequencing platform to
estimate sensitivity and specificity. To determine the effect of each
algorithmic step on performance, we evaluate the method with
each of three features (phasing, recalibration, and filtering) turned
off and compare these results to those achieved on the same data
with several other viral variant callers. Finally, we use V-Phaser on
data from a chronically HIV-1 infected subject to demonstrate its
utility to detect low frequency variants in viral populations.
Results
Using phased variants to increase sensitivity
Variant calling algorithms typically use a probabilistic or
empirical error model to define the distribution of errors, and
they recognize those candidates that fall outside of this distribution
as variants. We define the boundary between variants and errors
to be the variant detection threshold frequency (VDTF). To this definition,
we add the concept of phasing, where phased variants co-occur on
the same reads, to distinguish unphased VDTFs from phased VDTFs,
which separate phased variants from phased errors. V-Phaser uses
both phased and unphased VDTFs to increase sensitivity. If errors are
distributed uniformly at a rate p, we cannot use unphased VDTFs to
find variants that occur below this rate no matter how deeply we
sequence the population, since the unphased VDTF cannot fall
below p. In contrast, paired errors occur at the much lower rate of
p
2, and correlated variant pairs can be detected at much lower
frequencies than p, so long as that frequency remains above p
2 and
the depth of sequencing is sufficient. Theoretically, we can define
phased VDTFs for any pattern of variants, but in practice the only
patterns V-Phaser considers are paired variants in phase.
V-Phaser can call paired variants at a lower frequency using
phased VDTFs compared to unphased VDTFs, and given comparable
frequencies, V-Phaser can call phased variants at lower coverage.
We can calculate phased and unphased VDTFs as a function of
coverage and error rate (Figure 1). At any level of coverage and
error rate, the phased VDTF is lower than the unphased VDTF.I n
addition, the phased VDTF remains relatively flat over a range of
error rates, whereas the unphased VDTF manifests more dynamic
range, which suggests that compared to the unphased VDTF, even if
the probability model grossly misspecifies error rates, the phased
VDTF is relatively robust.
V-Phaser detects variants in phase when they occur on the same
reads, so to be on the same reads, variants need to be close to each
other. When variants are close together, many of the reads that
cover one variant will also cover the other variant, but when
variants are farther apart, fewer and fewer reads will begin and
end in just the right places to span both. At some point, the gain
Author Summary
New sequencing technologies provide unprecedented
resolution to study pathogen populations, such as the
single stranded RNA viruses HIV, dengue (DENV), and West
Nile (WNV), and how they evolve within infected
individuals in response to immune, therapeutic, and
vaccine pressures. While these new technologies provide
high volumes of data, these data contain process errors. To
detect biological variants, especially those occurring at low
frequencies in the population, these technologies require a
method to differentiate biological variants from process
errors with high sensitivity and specificity. To address this
challenge, we introduce the V-Phaser algorithm, which
distinguished the covariation of biological variants from
that of process errors. We validate the method by
measuring how frequently it correctly identifies variants
and errors on actual read sets with known variation.
Further, using data derived from a patient following four
years of HIV-1 infection, we show that V-Phaser can detect
biological variants at frequencies comparable to approach-
es that require prior knowledge. V-Phaser is available for
download at: http://www.broadinstitute.org/scientific-
community/software.
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this concept, we define the phase distance to be the farthest distance
from a locus such that compared to the unphased VDTF at that
locus, the phased VDTF is lower (i.e. more informative). If variants
are farther apart than the phase distance, they do not have enough
shared coverage to increase sensitivity. We show that the phase
distance is longer than half of the average read length for coverage
more than 65-fold, and as coverage increases, it approaches the
length of the average read (Figure 2). Just as increasing coverage
increases sensitivity to detect variants, it also increases the chances
to detect phased variants that are farther apart.
Pre-process filtering and recalibration of base quality
scores to increase specificity
Errors introduced by massively parallel sequencing technologies
can be correlated, and models to detect correlated variants can
also detect correlated errors, as well. On control read sets without
variants, we found that errors vary with base quality score, the
position of the base on the read, and the transition from the
previous base (Figure 3 a–c). DePristo et al. [17] use recalibration
equations in their Unified Genotyper to adjust for these
associations and call SNPs. V-Phaser minimizes false positive
correlated errors by filtering out errors and modeling the
correlations among errors. First, as detailed in the Materials and
Methods section, V-Phaser uses a read cleanup algorithm, Read-
Clean454 [24], to identify and correct process errors in the reads
and then utilizes a Neighborhood Quality Standard (NQS) criteria
to filter out low quality bases. From the remaining high quality
bases, V-Phaser builds an error probability model to adjust for
correlations.
Modeling base quality well is the key to achieving high
specificity, but highly variable viral sequences pose a difficult
challenge. To estimate the parameters, models are often fit to
highly conserved genomic regions without variation, but such
regions do not exist for small, diverse viral genomes. Models can
also be fit to empiric negative controls, but error rates can vary
from lane to lane or from run to run. Instead, V-Phaser uses an
expectation-maximization (EM) algorithm to iteratively fit its
probability model as it calls variants. Initially, V-Phaser treats all
mismatches as errors and estimates the parameters accordingly
using the recalibration equations of the Unified Genotyper [17]. In
the E step, V-Phaser uses the model to calculate the VDTFs to call
variants and remove them from the error list. Then in the M step,
V-Phaser updates the parameters to the model. V-Phaser iterates
until the number of variants called stabilizes.
Validating V-Phaser
To evaluate V-Phaser’s performance, we used read sets with
known variability generated by the 454 FLX sequencing platform.
Using these control data, we validated the variants called by the
comprehensive algorithm and also evaluated the contribution of
each core component of V-Phaser to the model’s sensitivity and
specificity. First, we assessed the effect of using or not using phased
variants by invoking a version of V-Phaser that only used unphased
VDTFs to identify variants. Second, we measured the effect of
using individual base quality scores utilizing a version of V-Phaser
that estimates two uniform error rates, for homopolymer and
nonhomopolymer regions. Finally, we tested the impact of low
quality base filtering invoking a version of V-Phaser without NQS
pre-processing filters. The positive control data were 454 read sets
derived from an artificial mixture of eight strains of West Nile
Virus (WNV) for which we knew the individual strain sequence.
We limited our analysis to regions of the genome covered by all
eight individual sequences. Differences among the individual
consensus assemblies defined the WNV variant set; a total of 110
variants were defined. We scored any error call that V-Phaser made
on this set of variants as a false negative, and any variant call as a
true positive.
Of the 110 variants in the WNV variant set, 102 variants were
detected with frequencies ranging from 0.3% to 47.5%, and a
median frequency of 11.3% (Table S1). Eight variants were not
observed on any sequence reads. V-Phaser called 100/102 variants
present in the data resulting in a sensitivity of 98% (Figure 4a),
including 15/17 (88%) of the variants at frequencies under 1%
(Figure 5 a–d). All versions of V-Phaser could detect 100% of the
variants above 2.5%, but without phased VDTFs V-Phaser could
Figure 1. Phase increased sensitivity to detect variants. Phase
increased sensitivity to detect variants, as seen over a range of error
rates at coverages of 100-fold, 250-fold, and 500-fold. The phased
variant detection threshold frequency (VDTF) is the lowest frequency of
reads with variants at two specific loci that V-Phaser can distinguish
from error among reads that span both loci. The unphased VDTF is the
lowest frequency of one variant that V-Phaser can distinguish from error
among reads that cover that locus. 100-fold phased sequence coverage
achieves comparable detection thresholds as 500-fold unphased.W e
use Equation 7 to calculate the phased and unphased VDTFs. (See the
Materials and Methods section for Equation 7 and its derivation.)
doi:10.1371/journal.pcbi.1002417.g001
Figure 2. Phase distance approached length of average read as
coverage increased. The phase distance was longer than half the
average read length for loci covered more than 65-fold, and as coverage
increased, it approached the length of the average read. The phase
distance is a measure of how far apart phased variants can be and still
be detected at lower frequencies than variants not in phase. We show
the phase distance as a percentage of average read length.
doi:10.1371/journal.pcbi.1002417.g002
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1.0% in frequency, and it still missed other variants with
frequencies as high as 2.4%. Of the remaining 10,004 loci
assumed to be non-variant based on consensus sequence
comparison, V-Phaser called 143 variants, for a putative specificity
of 99%. Out of 555 loci that showed variation in the mixture read
set but not in the parental strains, V-Phaser correctly called 74% of
them as errors. It is possible that many or most of the mistaken
variant calls could be artificial variants or mutations that were
introduced somewhere in the process of creating the mixture,
rather than sequencing errors.
Because of the unknown rate of novel variants introduced
during passage of the WNV samples, we used an infectious clone
(HIV NL4-3) as a negative control to more accurately measure the
specificity of V-Phaser. We scored any variant calls that V-Phaser
made on the negative control as a false positive, and any error calls
as a true negative. Among all loci in the negative control read set,
87% had no mismatches. Considering only the loci that harbored
variation, all versions of V-Phaser maintained specificity greater
than 97% if they incorporated individual base quality scores, but
for the version using uniform errors, the specificity fell to 91%
(Figure 4b). Among these sites with variation, V-Phaser called 29
sites that ranged in frequency from 0.4% to 5.6% as true variants;
some of these sites may actually be biological variants and not
process errors (see discussion below). If the composite Bernoulli
model correctly described the error distribution, then 95% of the
time V-Phaser would not make any false positive calls on the entire
sample. Clearly, the composite Bernoulli model fits the error
distribution better than a uniform error model, but the false
positives are evidence that at least some errors did not follow the
model.
We tested the validity of the composite Bernoulli model by
assessing how well the model fit the error distribution with and
without filtering using a quantile-quantile (q-q) plot as described in
the Materials and Methods section. Compared to the unfiltered
data, the filtered data produced a model that fit the observed error
distribution better (Figure 6 a–b). Without pre-processing filters, V-
Phaser systematically overestimated the probability of error. This
overestimation of the model seemed to be a function of the
number of low quality bases. As we sampled without replacement
from 1% to 100% of the reads, we saw an increasing skew in the q-
q plot (Figure S1 a–f). In addition, to test whether homopolymer
related artifacts in 454 sequencing were causing V-Phaser to
overcall variants, we examined the error calls made by V-Phaser on
the clonal HIV NL4-3 data. Since homopolymer related artifacts
systematically violate model assumptions, the resulting overcalls
would be expected to cluster in or near homopolymer regions.
False positives were not significantly more likely to be observed in
homopolymer nucleotide runs, nor in regions proximal to these
runs, as compared to residues outside of these regions, regardless
of whether a variant is called with phase or without phase (x
2 test
p.0.4 in all comparisons). These results were consistent if we
extended the homopolymer flanking regions to three or four
instead of two bases. Therefore, false positives appear to be
unrelated to homopolymer related artifacts and V-Phaser appears
to have no strong susceptibility to errors induced by system error
on the 454 sequencing platform.
Comparison to other variant calling algorithms
We ran several other variant calling programs on our control
data sets. The programs ShoRAH [12] and ViSPa [25] both
generated compute errors that were not easily resolved by the
Figure 3. Error rates were not uniformly distributed. Error rates varied by (A) read position, (B) base transition, and (C) base quality score. We
counted as errors any mismatches to the consensus assembly for each of the two runs in the control read set under the assumption that the NL-43
infectious clone had no diversity. We defined the read position relative to the beginning or end of the read, whichever was closer. We defined a base
transition as a dinucleotide representing the transition from the preceding base to the current base, and we scored a transition as an error if the
current base was a mismatch. Base quality scores came from the sequencing process.
doi:10.1371/journal.pcbi.1002417.g003
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Segminator II [21] and QuRe [13]. QuRe filters regions of the
genome that have less than 30-fold read coverage or are below
the 5
th percentile of coverage (defaults); as such comparison of
sensitivity and specificity across the various algorithms was
computed only across the bases interrogated by QuRe. Sensitivity
and specificity of the three programs, in addition to results for V-
Phaser with phasing turned off, are shown in Table 1. V-Phaser
outperformed both of the other programs in specificity. Although
Segminator II had 100% sensitivity, it achieved this at the expense
of a very high false positive rate, calling variants at more than
20% of the examined invariant sites. Notably, the counting of
inserted or deleted bases as false positives can significantly impact
reported specificities. V-Phaser reports a deleted base in two
instances while QuRe and Segminator II report 841 and six
respectively. Inclusion of indels in the measure of specificity
decreases QuRe’s specificity considerably (Table 1), but this likely
a less accurate measure of the algorithms specificity since such
errors could be easily filtered.
Applying V-Phaser to clinical data
We applied V-Phaser to data from an individual with chronic
HIV-1 infection taken from a larger study [24], and we analyzed
called variants by the frequency of these variants among the reads
at that position. Using just unphased VDTFs, V-Phaser called only
485 variants, none of which were ,1%; using no filtering, V-Phaser
called 1,778 variants; with phased VDTFs and filtering, V-Phaser
detected 2,015 variants, including 603 variants with frequency
,1% (Figure 7). Notably, V-Phaser detected variants down to
0.2%, a detection threshold comparable to allele-specific PCR
[26]. More than one out of every five loci had a recognized
Figure 4. Phase information increased sensitivity, and base
quality scores increased specificity. We compared V-Phaser to
alternate versions of V-Phaser with specific components disabled. In the
No Phase version, V-Phaser called variants without phase information. In
the Uniform Errors version, V-Phaser estimated uniform error rates
within homopolymer and nonhomopolymer regions without regard to
assigned base qualities. In the No Filtering version, V-Phaser did not
filter out low quality bases. (A) Phase information increased sensitivity.
The version without phase information attained a sensitivity of 90%, but
all other versions of V-Phaser used phase information and attained a
sensitivity of 97% or more. We calculated sensitivity as the percentage
of known variants correctly identified. Data are from WNV mixed
population control dataset. (B) Individual base quality scores increased
specificity. Among loci with mismatches, the Uniform Errors version had
only 91% specificity, but all other versions incorporated base quality
scores in their probability model and attained 97% specificity or more.
We calculated specificity as the percentage of loci in the control sample
correctly identified as having no variants among loci that had at least
one candidate variant. Data are from infectious clone (HIV NL4-3)
control dataset.
doi:10.1371/journal.pcbi.1002417.g004 Figure 5. Phase information increased sensitivity to detect
minor variants. Phase information increased sensitivity to detect low
frequency variants, as shown by these histograms of variants under
2.5%. All versions of V-Phaser detected 100% of the variants above 2.5%
frequency, so these variants are not shown here. All versions of V-Phaser
with phase information (A), (C), and (D) detected most variants below
1% in frequency, but the No Phase version (B) missed many variants
below 1% and some variants as high as 2.5%. Data are from control
WNV mixed population.
doi:10.1371/journal.pcbi.1002417.g005
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the positive predictive value was estimated as 98%. Of note, V-
Phaser identified 42 insertions or deletions (indels) as variants, and
V-Phaser detected 198 triallelic loci and 19 quadallelic loci.
Discussion
V-Phaser called rare variants in the presence of error in massively
parallel sequencing data of highly diverse viral populations with
.97% sensitivity and .97% specificity. Applied to a sample from
a chronically HIV-1 infected individual, V-Phaser could identify as
many as 603 minor variants at population frequencies of ,1%.
These variants were detected without a priori knowledge of the
specific mutations, and biological variants at frequencies as low as
0.2% were identified, comparable to the detection threshold of
allele-specific PCR, which is restricted to assaying known
mutations. In these data, V-Phaser called 42 indels and identified
more than 200 loci (roughly 2% of the genome) with more than
one variant.
In direct comparisons to two other recently published variant
callers, Segminator II [21] and QuRe [13], V-Phaser outperformed
both algorithms on specificity and outperformed QuRe on both
specificity and sensitivity. This is not surprising since QuRe
implements the error correction model of Wang et al. [27], which
only considers pileup information. In fact, if we turn off the
phasing portion of V-Phaser, it performs identically to QuRe on
sensitivity, but even better on specificity (Table 1). Segminator II
identifies all the true variants in the WNV mixed population data
Figure 6. NQS filtering improves fit of probability model to
data. (A) Quantile-quantile (q-q) plots under NQS filtering show good
fit of the probability model to the observed distribution of errors. Since
the probability model is discrete, p values are projected onto a uniform
distribution, and the distribution of projected p values is compared
with the expected null distribution. See Materials and Methods section
for details. (B) In contrast, q-q plots under no filtering show that no
filtering skews the calibration of the probability model used by V-
Phaser. Q-q plots of models based on subsets of the reads demonstrate
that this effect becomes more pronounced with increasing coverage
(see Figure S1). Q-q plots are scaled to fit curve, so y=x line is not at a
45 degree angle.
doi:10.1371/journal.pcbi.1002417.g006
Table 1. Comparison of V-Phaser to other viral variant callers.
Program Segminator II QuRe V-Phaser
V-Phaser (no
phasing)
Sensitivity 100.0% 89.0% 96.0% 89.0%
Specificity 88.% (88.8%) 97.1% (88.7%) 99.9% (99.9%) 99.7% (99.6%)
Sensitivities and specificities reported across residues interrogated by all
programs. Sensitivity is measured as the fraction of the known variants found
by each program in the WNV mixed population control data set. Specificity is
the fraction of sites not containing known variants that were called as invariant
in the HIV NL4-3 control data set; values reported in parentheses include
inserted and deleted bases (see Materials and Methods).
doi:10.1371/journal.pcbi.1002417.t001
Figure 7. Low frequency variants overwhelmingly called with
phase. Histogram shows low frequency variants overwhelmingly called
with phase thresholds. Variants frequencies are estimated by the
frequencies of variants among the reads at that position. Versions of V-
Phaser with and without phase thresholds called variants on a clinical
sample that are binned by their frequency at their locus. Most variants
,5% were detected only be V-Phaser with phase thresholds, and the
version without phase thresholds detected no variants ,1%.
doi:10.1371/journal.pcbi.1002417.g007
Rare Variant Detection in Mixed Viral Populations
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alignment-based read filtering only removes errors arising from
process-based indels while ignoring errors from other sources, such
as random substitution errors due to sequence misreads or PCR
errors in library construction.
The comprehensive V-Phaser model clearly outperformed the
model using uniform error rates, but the number of false
positives was higher than expected with the Bonferroni
correction. Some of these false positives detected in the
negative-control might actually be low level variants present in
the HIV NL4-3 cDNA libraries used to generate the read set that
had not been previously detected. Some might be errors
introduced early and amplified to create correlated errors not
modeled by V-Phaser. Particularly when considering the 454
sequencing process, which generates systematic errors in regions
around homopolymers, correlated error may occur in such
regions. However, we have multiple reasons to believe that this
has a small impact on the final V-Phaser calls. First, V-Phaser’s
base context model in the quality recalibration accounts for some
amount of homopolymer error. Second, our ReadClean454 read
cleanup step during the alignment phase removes or marks as
low quality the majority of errors derived from homopolymer
misreads or ‘‘carry forward and incomplete extension’’ (CAFIE)
errors (a related 454 error mode) [24]. Third, we examined the
error calls made by V-Phaser on the clonal HIV NL4-3 data to see
if they clustered in or near homopolymer regions, and we found
them to be randomly distributed with respect to homopolymer
regions. While the false positive rate was very low for the highly
diverse clinical sample we used, it could be higher for samples
with very low diversity since the false positive rate is inversely
proportional to the total number of true variants. Another
potential weakness of the model is the modeling of indels.
DePristo et al. [17] suggest that indel errors distribute differently
from other errors and need to be modeled differently. We did
not explicitly test V-Phaser for indel detection in the artificial
mixture used as the positive control, since the set of variants had
no indels.
V-Phaser uses phase information to increase sensitivity. Corre-
lated errors under the model are rarer than errors in general,
making it easier to call correlated variants. One potential problem
is the presence of chimeras, where one read is a composite from
two different genomes. Chimeras can decrease the correlation
between variants, but data from Hedskog, et al. [28] suggest that
chimeras occur rarely, making it difficult to significantly obscure
any correlation. The biggest limitation to using phase information
is the read length generated by the sequencing platform. We saw
that correlated variants need to be close enough to add to the
sensitivity, and that this phase distance is bounded by the average
read length (Figure 2). For the 454 platform the average read
length is over 500 bp, but for other platforms the average read
length is much shorter. This limitation could be overcome by
utilizing paired-end reads to extend the phase distance to cover
variants significantly farther apart.
V-Phaser is a variant calling tool that uses phase information to
increase sensitivity and models base quality to increase
specificity. V-Phaser is an effective tool to call variants in the
presence of errors from massively parallel sequencing data with
high specificity and high sensitivity. We designed V-Phaser to
overcome specific challenges to calling variants in small, diverse
viral genomes, but V-Phaser is general enough to analyze read sets
from other populations as well, such as metagenomic data and
tumor sequencing data, making it a novel algorithm with wide
utility.
Materials and Methods
Ethics statement
The subject gave written informed consent and the study was
approved by the Massachusetts General Hospital and granted
exemption by the Massachusetts Institute of Technology Review
Boards.
Statistical model
We construct a composite model of independent Bernoulli
random variables that are not identically distributed to allow error
rates to vary from base to base. We suppose that the base bik at
genomic locus i and read k is measured at an error rate pik, where
reads are aligned to a reference assembly with loci numbered from
1t ol, and reads at locus i are numbered from 1 to ni, the coverage
at locus i. We define the error random variable Eik to be 1 if bik is
measured incorrectly, and 0 otherwise. Let the random variable Xi
be the number of errors that occur at locus i:
Xi~
X ni
k~1
Eik ð1Þ
Under the special case that the errors are independent and
identically distributed Bernoulli random variables, such that pik=pi
for all reads k at locus i, Xi follows a binomial distribution, so the
probability fi(x) that x or more errors occur at locus i with coverage
of ni reads is as follows:
fi x ðÞ ~P(Xi§x)~
X ni
z~x
ni
z
  
pz
i 1{pi ðÞ
ni{z ð2Þ
More generally, if Xi is the sum of independent Bernoulli
random variables that are not identically distributed, we can
calculate fi(x) with the recursive application of the discrete
convolution formula, where we define the random variable Uir
as the number of errors that occur at locus i in the first r reads:
P Ui0~0 ðÞ ~1
P Uir~0 ðÞ ~ 1{pir ðÞ P Ui(r{1)~0
  
,0vrƒni
P Uir~r ðÞ ~pirP Ui(r{1)~r{1
  
,0vrƒni
P Uir~x ðÞ ~ 1{pir ðÞ P Ui(r{1)~x
  
z
pirP Ui(r{1)~x{1
  
,0vrƒni,0vxvr
fi x ðÞ ~P Xi§x ðÞ ~
X ni
z~x
P Uini~z
  
ð3Þ
We define the unphased variant detection threshold ti as the
smallest t such that fi(t) is statistically significant. To adjust for
multiple testing, we use the Bonferroni correction since errors are
uncorrelated under the null hypothesis. At a significance level a,
and applying the Bonferroni correction for testing the total
number of positions sequenced c, we calculate ti as follows:
ti~argmin
t
fi t ðÞ ƒa=c ðÞ ð 4Þ
If mismatches at position i occurred in t reads, we can infer if the
mismatches are variants by comparing t to ti.I ft is greater than or
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and at least one of them is a variant. If t is less than ti, then we infer
that we cannot distinguish these mismatches from error.
Under the probability model, errors are independent, but
variants can be phylogenetically related. Thus, we can also
distinguish variants from errors if mismatches at one locus are
correlated with mismatches at a different locus. In particular, we
define the error random variable Eijk to be 1 if errors occur at both
loci i and j on read k and 0 otherwise. Then the number of errors
Xij that occur in phase at both loci i and j, with shared coverage of
nij reads that span both i and j, is the sum of error random
variables as before. In the special case that errors are identically
distributed Bernoulli random variables, where pik=pi and pjk=pj
for all reads k that cover both loci i and j, we calculate the phase
probability gij(x) as follows:
gij x ðÞ ~P(Xij§x)~
X
nij
z~x
nij
z
  
pipj
   nij 1{pipj
   nij{z ð5Þ
In the more general case, we can calculate gij(x) by recursively
applying the discrete convolution formula as before, where we
define the random variable Uijr as the number of reads with errors
that occur at locus i and locus j among the first r shared reads:
P Uij0~0
  
~1
P Uijr~0
  
~ 1{pijr
  
P Uij(r{1)~0
  
,0vrƒnij
P Uijr~r
  
~pijrP Uij(r{1)~r{1
  
,0vrƒnij
P Uijr~x
  
~ 1{pijr
  
P Uij(r{1)~x
  
z
pijrP Uij(r{1)~x{1
  
,0vrƒnij,0vxvr
gij x ðÞ ~P Xij§x
  
~
X
nij
z~x
P Uijnij~z
  
At a significance level a and applying the Bonferroni correction
for testing the total number b of pairs of loci i and j such that gij is
defined, we can calculate the phased variant detection threshold tij
as follows:
tij~argmin
t
gij t ðÞ ƒa=b
  
ð6Þ
If we find phased mismatches at locus i and locus j on t reads, we
can infer if they are variants by comparing t to tij.I ft is greater
than or equal to tij, then we infer that not all of these mismatches
are errors. Otherwise, we cannot distinguish these mismatches
from errors.
We define the unphased variant detection threshold frequency (VDTF) Fi
to be the frequency at which we begin to distinguish variants from
errors at locus i and depth ni. Similarly, we define the phased VDTF
Fij to be the frequency at which we begin to distinguish phased
variants from errors at loci i and j and shared depth nij.W e
calculate Fi and Fij as follows:
Fi~ti=ni
Fij~tij=nij
ð7Þ
Sample preparation, assembly, and annotation of control
and sample read sets
We sequenced an HIV infectious clone (NL4-3) to serve as a
negative control for our validations and HIV RNA derived from a
clinical sample as previously described [24]. We derived the
positive control read set from eight individual primary WNV
strains isolated from mosquitoes and birds. Individual strains were
passaged once in C6/36 cells for amplification, and equal
concentrations of each strain were then pooled and used to infect
C6/36 cells at a multiplicity of infection of 0.1. Viral RNA was
isolated from these cultures (QIAmp viral RNA mini kit, Qiagen)
and the RNA genome reverse transcribed to cDNA using
Superscript III reverse transcriptase (Invitrogen), random hexa-
mers (Roche) and a specific oligonucleotide targeting the 39 end of
the target genome sequences. Four overlapping PCR products,
each of size ,3 kb, were designed to capture the WNV coding
region. PCR products were then pooled and sheared prior to
library construction.
To generate each read set, whole viral genomes were sequenced
using the Broad Institute’s viral genome sequencing and assembly
pipeline. Pooled PCR products (,3 kb) were amplified using
primer sets specific to either HIV or WNV, acoustically sheared,
and sequenced on the 454 Genome Sequencer FLX Titanium
(Roche) using standard protocols. The library was loaded into a
picotiter plate (PTP) to yield .200-fold read coverage. Resulting
sequence reads were trimmed of primer sequences, filtered for
high quality, assembled de novo and annotated using the Broad
Institute’s AssembleViral454 algorithm [24] and an in-house
annotation algorithm. Reference consensus assemblies used in
analyses are available from NCBI’s GenBank under accessions
HQ505665, JN819311, JN819312, JN819313, JN819315,
JN819318, JN819319, JN819320, JN819315, JQ403053, and
JQ403055; read data are available from NCBI’s Short Read
Archive (Project Accessions SRA045000 and SRA045569).
Alignment and preprocessing filters
Once we generated the sequence data, we aligned and
processed them using ReadClean454 algorithm as previously
described [24]. In particular, the algorithm corrects typical errors
introduced by the 454 sequences, including carry forward and
incomplete extension errors, homopolymer errors, and indels that
break the open reading frame (ORF). Any base rearrangements do
not affect the assigned base quality. Any insertions to preserve the
ORF consist of N bases with an assigned base quality of 1.
We then flagged each base to indicate if it passed the NQS
criteria [29]. A base met NQS criteria if its quality score was 20 or
higher and the five bases to either side all had quality scores of 15
or higher. We omitted the final NQS criterion that at least nine of
the ten flanking bases were perfect matches, since we expected the
HIV genome to be variable enough that variants among the
flanking bases could be relatively common [24]. For calling
variants, V-Phaser ignored any bases flagged as not meeting the
NQS criteria.
Estimation of model parameters by EM algorithm
Once we aligned and preprocessed the sequence data, we
estimated the model parameters and applied the model to the data
to call variants. In the uniform error case, we estimated error rates
in homopolymer and nonhomopolymer regions, where homopol-
ymer regions are defined by runs of 3 or more identical nucleotides
in a row. In the general case, we estimated error rates overall, per
base transition (where each transition was a dinucleotide consisting
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read position (distance from the start or end of the read, whichever
was closer). We then used these estimates in calibration equations
[17] to estimate the error rate for each base.
As V-Phaser called variants, it iteratively adjusted model
parameters using an EM algorithm. It initialized the algorithm
by treating all mismatches as errors to estimate error rates. In the
E step, it derived phased and unphased thresholds, called variants,
and removed these variants from the list of errors. In the M step, it
updated error rates due to the removal of called variants from the
error list. V-Phaser continued to iterate until it could call no more
variants.
Correlation of V-Phaser errors with homopolymers
To test whether homopolymer-related artifacts in 454 sequenc-
ing which violated the model assumptions were causing V-Phaser to
overcall variants, we divided the reference sequence of the clonal
HIV NL4-3 genome into three categories: homopolymeric regions
(defined as 3 or more of the same nucleotide in a row),
homopolymer flanking regions (defined as 2 bases to either side
of an homopolymeric region, representing the region in which
CAFIE errors are expected to occur), and non-homopolymeric
regions (the remainder of the genome). We then assigned each of
the false positive calls made by V-Phaser to one of these categories
and used a x
2 test (2 d.f.) to determine whether any region had
more variants than expected.
Construction of quantile-quantile plots
We use quantile-quantile (q-q) plots to assess the fit of our
probability models under the null. To assess the fit of the model to
the observed data, we compute the probability of observing each
datum under the model using F(x), the cumulative distribution
function (CDF), and compare the distribution of these observed
probabilities against the expected distribution of cumulative
probabilities under the null. For random variables with continuous
CDFs, the expected distribution under the null is the uniform
distribution between 0 and 1. For our probability models, the
expected distribution of probabilities under the null is more
difficult to calculate, since the CDF is discrete and varies from
locus to locus with the base qualities at that locus. Since our
models use discrete rather than continuous random variables, we
redistribute the mass of the probability mass function to construct
a uniform distribution. We define G(x), a projection of the
cumulative distribution function (PCDF) that maps the CDF
probabilities onto the uniform distribution in the following way:
G(F(x))~
b if a~b
Z otherwise, where Z*U(a,b)
(
a~ lim
y?x{ F(y)
b~F(x)
Conceptually, the PCDF redistributes massed probabilities
uniformly to bridge discontinuities in the CDF. For example, if
X is a random Bernoulli variable with success probability p and
failure probability q=12p and CDF FX, then FX(k)=0 for k,0,
FX(k)=q for 0#k,1, and FX(k)=1 for k$1. The discontinuities at
k=0 and k=1 correspond to the massed probabilities for X at
those values. G redistributes this mass uniformly to bridge the
discontinuity. So whenever X=0,G(FX(k=0)) uniformly takes on a
value between 0 and q, and whenever X=1,G(FX(k=1)) uniformly
takes on a value between q and 1. X can take on no other values, so
G(FX(k=X)) follows a uniform distribution between 0 and 1. So if
we have n observations of X, about p/n of them will be 1 and about
q/n of them will be 0. The expected cumulative probabilities for
each observed 0 will all be q, but their projected probabilities will
be uniformly distributed between 0 and q. Similarly, the projected
probabilities for each observed 1 will be uniformly distributed
between q and 1. If we sort the observations by their projected
probabilities, then the projected probability for the ith observation
will be very close to i/n. By construction, these projected
probabilities are uniformly distributed between 0 and 1 under
the null. So even though the CDFs vary by locus with the mix of
error rates among bases at that locus, the PCDF remains uniform.
Thus, we can compare the projected distribution of PCDF
probabilities against the expected distribution under the null,
which by design is the uniform distribution.
Comparison to other variant callers
We evaluated V-Phaser’s performance in terms of sensitivity and
specificity to detect variants relative to four other programs
designed for variant detection in viral quasispecies populations:
ShoRAH [12], ViSPa [25], Segminator II [21], and QuRe [13]. All
programs were run according to standard parameters defined by
the software authors. In all cases, we used the alignment and read
cleaning (if any) methods recommended by the authors. Only the
Segminator II and QuRe software packages successfully ran on our
datasets. For V-Phaser, we used our standard process including
ReadClean454 [24] to error correct and align the reads. In all cases,
we used our sample-specific consensus assemblies as the reference
for alignment. Sensitivity was computed using our WNV mixed
population control data set and specificity was determined using
the HIV NL4-3 infectious clone control data set. In scoring the
resulting calls, we ignored all inserted and deleted bases called (6
by Segminator II,2b yV-Phaser, and 841 by QuRe), because we could
not determine the exact number of discrete indel events called by
QuRe and felt that it would be unfair to count all 841 as errors since
such errors could be filtered (the data have no known indels based
on the input strain sequences).
Supporting Information
Figure S1 Impact of not filtering by NQS on model
calibration with increased coverage. Quantile-quantile (q-q)
plots for no NQS filtering data model show that the skew in the
calibration of the probability model used by V-Phaser increases with
increased sequence coverage. The impact of the skew is
demonstrated for (A) 5-fold, (B) 27-fold, (C) 52-fold, (D) 131-fold,
(E) 262-fold, and (F) 528-fold sequence coverage.
(TIF)
Table S1 V-Phaser variant calls in experimental WNV
mixed population. Eight parental strains of WNV were mixed
at equal proportions and then infected into mosquito cells and
allowed to proliferate, resulting in a final mixture with ratios set by
the relative replicative success of the strains. The nucleotide
sequence in each parental strain at residues known to contain a
mutation are shown and a ‘‘.’’ indicates the strain has the
dominant allele at that particular residue. Dominant residues are
noted in the variant column. The true proportion of the parental
strains in the sequenced mixture is not set, but since we know the
strain or strains of origin for all of the variants, we can infer the
mix of parental strain proportions that maximizes the likelihood of
observing the actual counts (including zero) of all parental alleles in
the sequencing data. The resultant frequencies are presented in
the ‘‘expected’’ column to provide an estimate of the true
frequency of the variants in the population. This allows us to
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process on our ability to detect variants of any given population
frequency.
(PDF)
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